Jefferies Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $24.7M | Buy |
48,688
+9,295
| +24% | +$5.2M | 0.21% | 74 |
|
|
2022
Q2 | $21.4M | Sell |
39,393
-7,344
| -16% | -$4.04M | 0.18% | 86 |
|
|
2022
Q1 | $27.6M | Buy |
46,737
+18,600
| +66% | +$10.7M | 0.17% | 89 |
|
|
2021
Q4 | $18.8M | Buy |
28,137
+16,551
| +143% | +$10.3M | 0.11% | 148 |
|
|
2021
Q3 | $6.62M | Buy |
11,586
+2,862
| +33% | +$1.57M | 0.05% | 367 |
|
|
2021
Q2 | $4.4M | Sell |
8,724
-62
| -0.7% | -$29.3K | 0.03% | 503 |
|
|
2021
Q1 | $4.01M | Sell |
8,786
-6,433
| -42% | -$3.07M | 0.04% | 452 |
|
|
2020
Q4 | $7.09M | Buy |
15,219
+9,469
| +165% | +$4.44M | 0.06% | 299 |
|
|
2020
Q3 | $2.54M | Sell |
5,750
-3,245
| -36% | -$1.34M | 0.03% | 484 |
|
|
2020
Q2 | $3.26K | Sell |
8,995
-6,868
| -43% | -$2.3M | 0.04% | 386 |
|
|
2020
Q1 | $4.5M | Buy |
15,863
+12,752
| +410% | +$4.02M | 0.05% | 355 |
|
|
2019
Q4 | $1.01M | Sell |
3,111
-16,637
| -84% | -$5.04M | 0.01% | 1455 |
|
|
2019
Q3 | $5.75M | Buy |
19,748
+18,948
| +2,369% | +$5.43M | 0.04% | 449 |
|
|
2019
Q2 | $235K | Buy |
+800
| New | +$220K | ﹤0.01% | 2048 |
|
|
2019
Q1 | – | Sell |
-2,672
| Closed | -$665K | – | 2633 |
|
|
2018
Q4 | $598K | Buy |
2,672
+549
| +26% | +$129K | ﹤0.01% | 1387 |
|
|
2018
Q3 | $518K | Sell |
2,123
-7,005
| -77% | -$1.61M | ﹤0.01% | 1622 |
|
|
2018
Q2 | $1.89M | Sell |
9,128
-302
| -3% | -$64.1K | 0.01% | 928 |
|
|
2018
Q1 | $1.95M | Buy |
9,430
+6,692
| +244% | +$1.4M | 0.01% | 881 |
|
|
2017
Q4 | $520K | Sell |
2,738
-22,610
| -89% | -$4.33M | ﹤0.01% | 1708 |
|
|
2017
Q3 | $4.8M | Sell |
25,348
-25,891
| -51% | -$4.69M | 0.03% | 550 |
|
|
2017
Q2 | $8.94M | Sell |
51,239
-2,908
| -5% | -$488K | 0.06% | 307 |
|
|
2017
Q1 | $8.32M | Sell |
54,147
-30,260
| -36% | -$4.63M | 0.06% | 322 |
|
|
2016
Q4 | $11.9M | Buy |
84,407
+76,847
| +1,016% | +$11.3M | 0.07% | 286 |
|
|
2016
Q3 | $1.2M | Buy |
7,560
+2,929
| +63% | +$451K | 0.01% | 1190 |
|
|
2016
Q2 | $684K | Buy |
4,631
+4,031
| +672% | +$595K | ﹤0.01% | 1295 |
|
|
2016
Q1 | $85K | Sell |
600
-1,150
| -66% | -$154K | ﹤0.01% | 1986 |
|
|
2015
Q4 | $248K | Buy |
+1,750
| New | +$233K | ﹤0.01% | 1862 |
|
|
2015
Q3 | – | Sell |
-7,456
| Closed | -$967K | – | 3012 |
|
|
2015
Q2 | $967K | Sell |
7,456
-2,917
| -28% | -$380K | 0.01% | 1248 |
|
|
2015
Q1 | $1.39M | Buy |
10,373
+124
| +1% | +$16K | 0.01% | 900 |
|
|
2014
Q4 | $1.28M | Buy |
10,249
+1,114
| +12% | +$135K | 0.01% | 878 |
|
|
2014
Q3 | $1.11M | Sell |
9,135
-43,056
| -82% | -$5.24M | 0.01% | 966 |
|
|
2014
Q2 | $6.16M | Buy |
52,191
+12,541
| +32% | +$1.48M | 0.05% | 309 |
|
|
2014
Q1 | $4.77M | Buy |
39,650
+36,412
| +1,125% | +$4.33M | 0.05% | 320 |
|
|
2013
Q4 | $360K | Sell |
3,238
-18,724
| -85% | -$1.86M | ﹤0.01% | 1294 |
|
|
2013
Q3 | $2.02M | Buy |
21,962
+17,886
| +439% | +$1.62M | 0.02% | 592 |
|
|
2013
Q2 | $345K | Buy |
+4,076
| New | +$339K | ﹤0.01% | 1231 |
|
Other funds holding TMO
Jefferies Group's TMO Position: Q3 2022 in Review
Jefferies Group increased its Thermo Fisher Scientific (TMO) stake by 24% in Q3 2022, buying an estimated $5.2M and bringing the position to 48,688 shares worth $24.7M. The position accounts for 0.21% of the portfolio, ranked #74.
Jefferies Group first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $27.6M in Q1 2022. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.
- Jefferies Group held 48,688 shares of Thermo Fisher Scientific worth $24.7M as of Q3 2022.
- Jefferies Group bought 9,295 Thermo Fisher Scientific shares in Q3 2022, an estimated $5.2M.
- Thermo Fisher Scientific made up 0.21% of Jefferies Group's portfolio in Q3 2022, its #74 holding.
- Jefferies Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's Thermo Fisher Scientific position peaked at $27.6M in Q1 2022.
- 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.